| __timestamp | Alnylam Pharmaceuticals, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 40028000000 |
| Thursday, January 1, 2015 | 41097000 | 39203000000 |
| Friday, January 1, 2016 | 47159000 | 40495000000 |
| Sunday, January 1, 2017 | 76545000 | 41306000000 |
| Monday, January 1, 2018 | 73106000 | 42399000000 |
| Tuesday, January 1, 2019 | 194688000 | 41531000000 |
| Wednesday, January 1, 2020 | 414801000 | 33216000000 |
| Friday, January 1, 2021 | 704143000 | 50467000000 |
| Saturday, January 1, 2022 | 868601000 | 65986000000 |
| Sunday, January 1, 2023 | 1517886000 | 28809000000 |
| Monday, January 1, 2024 | 1924873000 | 45776000000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, the battle for supremacy in gross profit generation is a captivating narrative. From 2014 to 2023, Pfizer Inc. consistently outperformed Alnylam Pharmaceuticals, Inc. in terms of gross profit. Pfizer's gross profit peaked in 2022, reaching a staggering 66 billion, while Alnylam's highest was approximately 1.5 billion in 2023. Despite Alnylam's impressive growth, increasing its gross profit by over 3,000% from 2014 to 2023, it remains dwarfed by Pfizer's financial might. This comparison highlights the scale and reach of Pfizer, a pharmaceutical behemoth, compared to the innovative yet smaller Alnylam. As the industry continues to innovate, the dynamics between established giants and emerging players will shape the future of healthcare.
Key Insights on Gross Profit: Merck & Co., Inc. vs Alnylam Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing AstraZeneca PLC and Alnylam Pharmaceuticals, Inc.
Comparing Revenue Performance: Pfizer Inc. or Alnylam Pharmaceuticals, Inc.?
Pfizer Inc. vs Ascendis Pharma A/S: A Gross Profit Performance Breakdown
Pfizer Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Zoetis Inc. and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Takeda Pharmaceutical Company Limited and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.